Reliject Pre Injection Wipe Box of 100

Reliject (Reliance Medical)

Medical & First Aid Supplies

Pre-injection skin cleansing swabs

Formulated and labelled in accordance with EU/UK CLP classification for isopropanol Containing preparations.
Supplied with a Material Safety Data Sheet (MSDS) detailing composition, hazards and handling for Reliance Medical product reference 742.

Formulated and labelled in accordance with EU/UK CLP classification for isopropanol Containing preparations.
Supplied with a Material Safety Data Sheet (MSDS) detailing composition, hazards and handling for Reliance Medical product reference 742.

Pre-injection skin cleansing swabs

Description

Reliject Pre-Injection Wipe (Box of 100) is a box of individually wrapped, 2-ply pre-injection skin cleansing swabs manufactured by Reliance Medical under the Reliject brand. Each non-woven wipe is impregnated with 70% isopropyl alcohol solution for rapid skin disinfection before injections and minor procedures. The swabs are designed for skin preparation prior to administering injections, helping to reduce the risk of infection at the injection site. They are supplied in sealed sachets to maintain sterility and saturation, dry rapidly after use, and are suitable for use in healthcare, first-aid, vaccination, phlebotomy, and aesthetic injection settings.

Bnefits

Provides rapid skin cleansing and disinfection prior to injections with 70% isopropyl alcohol.
Helps reduce the risk of infection at the injection site when used as part of good clinical practice.
Individually wrapped sachets help maintain sterility and prevent cross-contamination.
2-ply non-woven construction offers sufficient strength and absorbency while remaining compact.
Dries rapidly, allowing injections to be given promptly after skin preparation.
Convenient box of 100 swabs suitable for clinics, surgeries, vaccination centres, first-aid rooms and aesthetic practices.
Single-use, disposable design supports good infection prevention and control protocols.

Indications

Pre-injection skin preparation on intact skin before intramuscular, subcutaneous, or intradermal injections.
Skin cleansing prior to venepuncture, finger-prick tests, cannulation and similar minor procedures.
Use in healthcare, first-aid, occupational health and aesthetic medicine settings where small-area skin disinfection is required on intact skin.
Adjunct to standard aseptic technique as part of infection prevention and control procedures.

Composition

Non-woven 2-ply wipe substrate (white wet non-woven material).
Impregnated with 70% v/v isopropanol (isopropyl alcohol; CAS 67-63-0, EC 200-661-7) aqueous solution.
Residual 30% vehicle primarily purified water and minor processing excipients as per manufacturer’s formulation.

Formulation

Ready-to-use pre-injection skin cleansing wipe.
2-ply non-woven swab impregnated with 70% isopropyl alcohol solution.
White, wet, non-woven material with weak penetrating odour characteristic of isopropanol.
Supplied sterile and individually sealed in sachets for single use.

Packaging

Box containing 100 individually wrapped Reliject pre-injection swabs.
Each swab is sealed in a single-use sachet to maintain sterility and saturation.
Outer carton printed with product name, brand (Reliject / Reliance Medical), quantity (box 100), key features (2-ply, 70% isopropyl alcohol, individually wrapped) and basic usage information.
Manufacturer reference number 742 used by Reliance Medical for the pre-injection swabs (box of 100).

Usage

For external use on intact skin only.
Tear open the individual sachet immediately before use and remove the swab.
Apply the swab to the area of intact skin where the injection or procedure will be performed.
Wipe the area thoroughly using firm, circular motions from the injection site outward, ensuring complete coverage.
Allow the skin to air-dry completely to ensure maximal antiseptic effect and to reduce stinging before performing the injection or procedure.
Use each swab once only and discard safely after use in accordance with local infection control and clinical waste policies.
Do not reuse or re-saturate the swab. Do not apply to mucous membranes, eyes, large areas of skin, or broken/damaged skin.
Avoid contact with flames, sparks and other ignition sources; isopropyl alcohol is highly flammable.
Follow local clinical guidelines and aseptic technique recommendations in addition to using the swab.

Contraindications

Known hypersensitivity or allergy to isopropyl alcohol (isopropanol) or any component of the wipe.
Do not use on broken, irritated, eczematous, or extensively damaged skin unless directed by a healthcare professional.
Not suitable for use on mucous membranes, in the eyes, in the mouth, or in large body areas.
Use with caution in neonates or premature infants due to risk of excessive absorption or skin irritation.
Avoid use in individuals where alcohol-based products are contraindicated or not recommended by clinical guidance.

Adverse Effects

Transient stinging, burning or mild irritation at the application site, especially on sensitive skin.
Dryness or mild erythema of the skin after repeated use.
Allergic or irritant contact dermatitis to isopropanol or other components of the wipe (rare).
If used improperly on broken skin or large areas, potential for systemic absorption of isopropanol with associated toxicity, though this is unlikely under normal intended use.

Storage Conditions

Store in a cool, well-ventilated place away from direct sunlight and sources of ignition.
Keep the box tightly closed when not in use and protect from excessive heat.
Store only in the original packaging and do not decant individual sachets into other containers.
Keep out of reach of children.
Observe any expiry date printed on the packaging and do not use after the expiry date.

Duration

Single-use per application; used immediately before each injection or minor procedure as part of routine skin preparation, with no defined long-term treatment course.

Onset

Antiseptic effect is rapid on contact, with practical use typically involving application and complete drying within approximately 30 seconds to 1 minute before injection.